Corporate and Financial Strategy Services
In the current credit crunch and economic recession, increased focus is being put on maintaining liquidity and reducing costs and all of the activities that are usually driven by the CFO. The current situation is putting additional pressure on the life science industry, which is already struggling with increasing regulatory pressure, slowing productivity and all the present cost management initiatives. Today’s CFOs and finance directors are faced with a complex, constantly changing business environment in which their companies need to be supported by a flexible finance function that delivers transparent, efficient, forward-looking insight, while at the same time managing risk and compliance, effectively deploying and allocating scarce resources.